PDS Biotechnology is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
PDS Biotechnology is a publicly traded company on NMS using the ticker symbol EDGE.
Detailed information on company financials and operating reports can be found here:
NMS: EDGE
Note: PDS Biotechnology's revenues are gauged from an analysis of company filings.
Investor Activity
PDS Biotechnology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 9, 2015
19
100%
$56 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that PDS Biotechnology is developing and marketing.
PDS Biotechnology doesn't have any recent trademark applications, indicating PDS Biotechnology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
INFECTIMUNE Pharmaceutical research services, namely, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates
11/22/2021
PRECISA Platform as a service (PAAS) featuring technology for use in researching, developing and manufacturing polymer based therapeutics by users in the pharmaceutical field
10/07/2016
PRECISA PLATFORM Platform as a service (PAAS) featuring technology for use in researching, developing and manufacturing polymer based therapeutics by users in the pharmaceutical field
10/07/2016
See all trademarks and details in the Full Report.
Market Share of PDS Biotechnology's Largest Competitors
A competitive analysis shows these companies are in the same general field as PDS Biotechnology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to PDS Biotechnology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as PDS Biotechnology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.